Literature DB >> 3812082

Antitumor activity and biochemistry of novel analogs of the antibiotic, CC-1065.

W Wierenga, B K Bhuyan, R C Kelly, W C Krueger, L H Li, J P McGovren, D H Swenson, M A Warpehoski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3812082     DOI： 10.1016/0065-2571(86)90012-9

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN： 0065-2571


× No keyword cloud information.
  6 in total

1.  In vitro evaluation of a novel chemotherapeutic agent, Adozelesin, in gynecologic-cancer cell lines.

Authors:  H N Nguyen; B U Sevin; H Averette; J Perras; R Hightower; R Ramos; D Donato; M Penalver
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Pharmaceutical development of a parenteral formulation of the novel anti-tumor agent carzelesin (U-80,244).

Authors:  J D Jonkman-de Vries; M J de Graaff-Teulen; R E Henrar; J J Kettenes-van den Bosch; A Bult; J H Beijnen
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

3.  Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065.

Authors:  L H Li; R C Kelly; M A Warpehoski; J P McGovren; I Gebhard; T F DeKoning
Journal:  Invest New Drugs       Date:  1991-05       Impact factor: 3.850

4.  Structure and activity relationship of several novel CC-1065 analogs.

Authors:  L H Li; T L Wallace; T F DeKoning; M A Warpehoski; R C Kelly; M D Prairie; W C Krueger
Journal:  Invest New Drugs       Date:  1987-12       Impact factor: 3.850

Review 5.  CC-1065 and the duocarmycins: unraveling the keys to a new class of naturally derived DNA alkylating agents.

Authors:  D L Boger; D S Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

6.  The Difference a Single Atom Can Make: Synthesis and Design at the Chemistry-Biology Interface.

Authors:  Dale L Boger
Journal:  J Org Chem       Date:  2017-10-13       Impact factor: 4.354
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.